Achieve Life Sciences (ACHV) Non-Current Deferred Tax Liability (2016)

Achieve Life Sciences' (ACHV) quarterly Non-Current Deferred Tax Liability came in at $124000.0 in Q4 2016.

Achieve Life Sciences (ACHV) Non-Current Deferred Tax Liability (2016) Analysis & Trends

Achieve Life Sciences (ACHV) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $124000.0 in Q4 2016.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $124000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $124000.0 (changed N/A YoY) and the FY2016 annual result came in at $124000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability steadied at $124000.0 in Q4 2016.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $124000.0 in Q4 2016 to a low of $124000.0 in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Achieve Life Sciences	330.88 Mn	330.88 Mn	-

Download Data

Date	Value
Dec 31, 2016	124,000.00
Dec 31, 2016	124,000.00